A clinical trial to study the effect and safety of Lobeglitazone Vs. Pioglitazone in Diabetic patients.
Phase 3
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2024/03/063774
- Lead Sponsor
- Balamurugan M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient willing to give informed consent form.
Patient with Body mass index 18.5 to 25
Exclusion Criteria
Patients with other complications like cardiac, renal, gastrointestinal, and hematological disorders.
Patients has undergone major surgery.
A patient who has known or suspected hypersensitivity to the study drugs.
Patients with pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Glucose (FBG) <br/ ><br>Post Prandial Blood Glucose(PPBG) <br/ ><br>HbA1CTimepoint: 1 month Interval
- Secondary Outcome Measures
Name Time Method ipid ProfileTimepoint: 3 months interval